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1726-31 Functional Mitral Regurgitation Correlates with
Incomplete Mitral Valve Closure not Left Ventricular
Sphericity in Active Myocarditis
Lisa A. Mendes, Michael H. Picard, G. William Dec, Igor F Palacios, Ravin Davidoff,
Myocarditis Treatment Trial Investigators. Boston University Medical Center,
Massachusetts General Hospital, Boston, MA
Incomplete mitral valve (MV) closure and LV sphericity correlates with func-
tional MR in chronic dilated cardiomyopathy. To assess the mechanism of MR
in active myocarditis (M) echocardiograms performed within 5.7 ± 1.2 days
of initial RV biopsy in 27 pts with histologically proven M enrolled in the My-
ocarditis Treatment Trial were analyzed. M pts were stratified into those with
mild MR (:::1 +, n ~ 14) and moderate MR (:;:2+, n ~ 13). LV volume (vol) was
measured and a sphericity index (SI) calculated. A value approaching 1 rep-
resents increased sphericity. Mitral annular (MA) diameter (d), the distance
(DIS) between MV leaflet coaptation and MA plane, and the area enclosed by
MVand MA (MVarea) were measured and compared to 20 normal controls.
MAd (em) Dl5{cm) MVarea (cm2) LVvol (cc/m2 ) 51
Control 23±02 0.32 ± 013 034±013 49.5 ± 79 0.36 ± 0.05
:01+ MR 3.1±0.4' 0.60 ± 0.14' 1.2 ± 0.45' 79.7 ± 28.9' 0.47 ± 0.10'
>2+ MR 3.9 ± 0.5' 0.96 ± 0.18' 23 ± 0.64' 78.3 ± 29.1" 0.48 ± 0.09"
'p < 0.0001 compared to control, 1p = N5 compared to:ol + MR
Conclusion: In active M, functional MR does not correlate with increasing
LV sphericity. Incomplete MV closure and MA dilatation are more important
correlates of MR severity.
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Favorable Long-term Outcome of Severe Acute
Myocarditis in Children not Receiving
Immunosuppressive Therapy. A Comparative Study
with Adult Patients
Manuel Anguita, Federico Valles, Francisco Torres, Jose M. Arizan, Diego Gimenez,
Ignacio Tejero, Jose Suarez de Lezo. Hospital Reina Soffa, Cordoba, Spain
With the aim to study spontaneous long-term outcome in children with se-
vere acute myocarditis (AM) not receiving immunosuppressive drugs, and to
compare children evolution with that of adults with AM, we have prospec-
tively assessed 50 patients (15 children, 35 adults) with AM and severe left
ventricular dysfunction (left ventricular ejection fraction [LVEFj <40%1 diag-
nosed in our hospital in the last 8 years. Immunosupressive therapy was not
used in any patient. Children age ranged from 2 months to 12 years (mean:
2 ± 3 years). Initial LVEF was 30 ± 12% in children and 28 ± 10% in adults
INS). After a follow-up of 21 ± 16 months (range: 1-80),3 children (20%) and
9 adults (26%) died or required heart transplantation (HT). Probability of being
alive and free from HT at 2 years was 75% in children and 60% in adults. LVEF
rose at 1 month to 45 ± 14% in children and to 36 ± 13% in adults (p < 0.05),
and to 58 ± 15% in children and 40 ± 16 in adults at the end of follow-up (p
< 0.01). Unfavorable outcome (death, HT or chronic dilated cardiomyopathy
with LVEF <45%) occurred in 4 children (16%) and 16 adult patients (46%) (p
< 0.05). A lower«30%) l-month LVEF and an unfavorable 1-month evolution
were the most powerful predictors of non-favorable long-term outcome (p <
0.001). In conclusion, long-term evolution of children with severe AM not re-
ceiving immunosuppressive drugs is favorable in most cases, and it appears
to be better than in adults. Nevertheless, patients in whom LVEF does not im-
prove at short-term appear to be at higher risk for death, and they should be
considered for HI.
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1726-51 Autoantibodies to Stress Proteins in Dilated
Cardiomyopathy and Biopsy Proven Myocarditis
Irene Portig, Sabine Pankuweit, Friedrich Lottspeich 1, Bernhard Maisch.
Department of Internal Medicine-Cardiofogy, Philipps-University Marburg, Germany;
1 Max-Planck-Institute of Biochemistry, MIJnchen-Martinsried, Germany
Stress proteins are synthesized either constitutively or in response to heat
shock or other metabolic insults. Stress proteins are immunodominant anti-
gens of mycobacteria and other nonviral microorganisms and have been
highly conserved during evolution. Stress proteins have therefore been
thought to be involved in the pathogenesis of various autoimmune diseases.
As myocarditis and dilated cardiomyopathy (DCM) are both thought to be
initiated by autoimmune mecha nisms, we looked for autoa ntibodies to stress
proteins. Through their exposed situation in the vasculature, endothelial cells
may participate in the initiation of these diseases. We therefore used both
purified stress proteins and stressed endothelial cells as antigenic substrate.
Methods; Sera were obtained from healthy controls and patients with di-
lated cardiomyopathy and biopsy proven myocarditis. Endothelial cells were
isolated from umbilical veins by collagenase digestion, cultivated to the 2nd
or 3rd passage, and then subjected to a heat shock (45°C, 15 min). The cells
were allowed to recover for 16 h at 37"C, scraped off the culture vessel, and
lysed in an urea buffer. The cell lysate or purified hsp 90 and 27 was then used
in a 1D and 2D-immunoblot.
Results;
Diagnosis N Antibodies against
purified hsp 27 hsp 90 cell lysate
OCM 113 15/13% 413.5% 41/36%
Myocarditis 62 9/14.5% 4/6.5% 38/61%
Controls 96 9/9% 7f7% 23/24%
Conclusion; In the sera of patients with DCM and myocarditis antibodies
to endothelial proteins were found, indicating that antiendothelial antibodies
may be involved in the pathogenesis of these diseases. In contrast, autoan-
tibodies to stress proteins were not found in significantly higher number in
the sera of patients as compared to healthy controls. A role of autoantibodies
to hsp 27 and hsp 90 in the pathogenesis of these diseases can thus not be
assumed.
05:15
1726-61 Diastolic Left Ventricular Function Improves in
Patients with Healed Myocarditis Compared to
Patients with Ongoing Myocarditis
Christiana M. Schannwell 1, Igor Janda I, Uwe Kuhl l , Nicola Roediger I, Otto
N. Krogmann 1, Markus Jacob 2, Heinz-P. Schultheiss 1, Bodo E. Strauer 1.
1 University Dusseldorf. Germany; 2 University Zurich, Switzerland
In order to evaluate whether there are hemodynamic differences be-
tween patients (P) with healed or ongoing myocarditis (MC) biplane LV-
angiocardiography and high fidelity pressure measurements were performed
in 49 P compared to 12 controls (CI. Diagnosis of MC was based on clinical
presentation and right ventricular endomyocardial biopsy (lymphocytic infil-
tration, enhanced expression of human class 1 and 2 antigens). In the follow-
up (FU) biopsy after 3 months lymphocytic infiltration resolved in 16 P (Pl),
and persisted in 33 P(P2). Systolic and diastolic LV-function in Pwith MCwas
depressed when compared to C. At FU LV-ejection fraction did not increase
whereas diastolic LV-function (time constant of relaxation (T:ms), constant of
myocardial stiffness (b)) did improve significantly in Pl whereas it remained
unchanged or even decreased in P2. However it was still depressed when
compared to C.
EF LMMI LVEDP LVEDVI T b
C 64 86 11 86 45 11
FU FU FU FU FU FU
PI 48"52" 148*"122" 18*"13 146*"128" 103*"59'" 35'018'
P2 49"50" 146"141" 20"19" 142"141" 90"91" 36*" 51"
EF: LV-ejection fraction (%). LMMI: LV-muscle mass index (g/m 2 ), LVEDVI: LV-
enddiastolic volume index{ml/m2), LVEDP: LV-enddiastolic pressure (mmHg): *: p < 0.05
vs. FU, ': p < 0.05 vs P2, "; P< 0.05 vs C
Conclusion: The healing process in myocarditis seems to improve active
and passive LV diastolic properties before LV systole is positively effected.
Endogenous Influence on Failing Intact
Myocardium
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1727-1 1 The Role of Sympathetic Activity in Murine
Myocarditis Leading to the Development of Dilated
Cardiomyopathy
A. Shakir Pandey, Michael J. Sole, John S. Floras, Fayez Dawood, Wen-Hu Wen,
Lily Wee, Peter Liu. The Toronto Hospital, Centre for Cardiovascular Research,
University of Toronto, Canada
Sympathetic activation occurs in heart failure, but it is not known how much
this process actually contributes to the development of cardiomyopathy. Ac-
cordingly we tested the effect of total peripheral ganglionic blockade using
a novel approach with oral Chlorisondamine (Chlor) in a murine model of
myocarditis-dilated cardiomyopathy. Chlorisondamine inhibits sympathetic
output at the peripheral level. DBA/2 mice (n = 1101 received 10 pfu of en-
cephalomyocarditis virus and were randomized to Chlor(l 00 mglkg p.o. start-
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ing day 4 of infection. LD50 = 300 mg!kg). placebo or uninfected controls.
The pathology and microvasculature were blindly scored. and whole heart
norepinephrine (NE) content determined by HPLC. The mean cardiac NE and
pathological scores on day 28 (cardiomyopathy stage) are:
Chlor Placebo Unlnfected
Ilg/kg/min. ic). and subjected to four 8 minute periods of regional ischemia
(LAD occlusion) and reperfusion, Myocardial segment shortening (55) was
monitored throughout the stunning protocol and for 2 hours following the fi-
nal occlusion. Results: (55. % of baseline. ' p < 0,05 vs. saline. t p < 0,05 vs,
corresponding dose of GP531 alone):
NE (nM/L)
Path Score
5362 ± 389*
1.3 ± 0.6*
3382 ± 170
30 ± 0.1
5719 ± 60
00 ± 0.0
Treatment Baseline Occlusion 4 Reperfusion
1 hr 2 hr
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There was also significant amelioration of microvascular spasm in the Chlor
treated hearts. The mortality decreased from 42% (20/48) to 32% 114/44. p <
0.05).
We conclude that ganglionic blockade prevents the reduction in cardiac
norepinephrine levels in this murine model of myocarditis-cardiomyopathy.
Blocking sympathetic activation can significantly reduce the mortality. patho-
logical damage and microvascular angiopathy in the multifactorial process
leading from initial cardiac damage to the development of cardiomyopathy.
19 ± 2
38 ± 4'
57 ± 3'
30 ± 4,t
57 ± 1
36 ± 1*
45± 1*+
41 ± 1*+
MYOVEL Illm/sl
15 ± 2
39 ± 8'
47 ± 3'
31 ± 6,t
4.0 ± 0,1
2.3±0,1*
3.0 ± 0,1*+
2.6±0.1*
MYO%
-15±4
-10± 5
-11 ±6
-19± 5
226 ±7
257 ± 9*
236 ± 13
183± 14*+
APDSO Imsl
100
100
100
100
158± 9
121 ± 5*
154 ± 10+
165 ± 13+
Vmax (Vis)
-78 ± 0.8
-71 ± 0,8*
-74 ± 1*+
-76 ± 1+
RMP(mV)
Saline In ~ 6)
GP531 (1. n ~ 5)
GP531 (10. n ~ 6)
8SPT + GP531 (10. n ~ 4)
CONTROL
DCM
OCM/ACEI
OCM/AT-BLOCK
, p < 0.05 vs. saline. t p < 0.05 vs, corresponding dose of GP531 alone
*p < 0.05 vs CONTROL. +p < 0,05 vs DCM
MYO membrane potential at the end of MYO contraction increased with
DCM and DCM/ACEI (4.9 ± 1.9*.4.4 ± 2.4*mV) compared to CONTROL (0.8
± 0.3 mY) but was normalized with DCM/AT-BLOCK (1.4 ± 0.9 mY). Thus.
ACEI during the progression of DCM improved MYO function whereas AT-
BLOCK had selective effects on MYO electrophysiology.
Summary: These findings suggest that ACEI and AT-BLOCK have unique
and different mechanisms of action with cardiomyopathic disease.
Differential Effects of Chronic Angiotensin
Converting Enzyme (ACE) Inhibition and Angiotensin
II (AT-II) Receptor (AT1 AT-II) Blockade on Myocyte
Excitation and Contraction In Dilated
Cardiomyopathy
Rupak Mukherjee, Henry H, Holzgrefe, James R, Powell. William H. Koster, Francis
G. Spinale. Med Univ ofSouth Carolina, Chas. SC; Bristol Myers Squibb Research
Institute. Princeton. NJ
AT-II production and AT1 AT-II receptor activation have been suggested to
contribute to the progression of dilated cardiomyopathy (DCM). However.
the direct effects of chronic ACE inhibition (ACEI) or specific ATl AT-II re-
ceptor blockade (AT-BLOCK) on myocyte (MYO) electrophysiology and con-
tractility with the progression of DCM are unknown. Accordingly. simulta-
neous indices of isolated MYO membrane potential (resting; RMP. max up-
stroke velocity; Vmax, time to 90% repolarization; APD90) and contraction
Ipercent; MYO% and velocity of shortening; MYOVEL) were obtained from
4 groups of dogs (n = 6/group): DCM; chronic pacing (216bpm; 4 weeks).
DCM/ACEI; chronic pace and concomitant ACEI (fosinopril; 30 mg!kg BID).
DCM/AT-BLOCK; chronic pace and treatment with a specific non-peptide AT1
AT-II antagonist (BMS-186295; 30 mg!kg BID), and CONTROL.
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GP531 improved functional recovery in stunned myocardium. and this was
prevented by adenosine receptor blockade with 8SPT, GP531 did not affect
baseline hemodynamics or myocardial function. confirming receptor binding
studies indicating that it is not a direct ADO receptor agonist. We conclude
that GP531 protects the myocardium from ischemic injury in anesthetized
pigs primarily via regulation of endogenous adenosine,
B
mI02/beat/l 00 9
mV02-PVA:A
ml02 /mmHg,ml
Vo
ml/l00 9
ESPVR: Ees
mmHg/ml.l00 9
Mean ± SEM. *p < 0.05 vs. Placebo
1727-21 Changes in Left Ventricular Mechanics and
Energetics in Canine Microembolization Model of
Heart Failure
Koji Todaka. Shu-Ming Zhu. Anguo Gu. Richard Stemett. Daniel Burkhoff. Columbia
University. New York. NY
Myocardial mechanics and energetics have been shown previously to be
markedly abnormal in a canine model of pacing induced heart failure. How-
ever. whether those abnormalities pertain to other. more clinically relevant
forms of heart failure is unknown. To investigate this question, heart failure
was created by ischemic damage in 6 dogs (CHF group) that underwent re-
peated coronary microsphere injections over 2 months resulting in afinal area
ejection fraction (aEF) of 34 ± 4%. A control group of 6 normal dogs had
an aEF of 46 ± 8%, Hearts of these animals were isolated, cross-perfused
and balloons placed in the LV to control volume. We measured the LV end-
systolic (ESPVR) and end-diastolic (EDPVR) pressure-volume relations and
the relationship between oxygen consumption (mV02) and pressure-volume
area (PVA). p-responsiveness of the CHF group was significantly depressed
compared to control as assessed by the increased amount of isoproterenol
required to increase peak isovolumic LV pressure by40% (72 ± 36 vs. 29 ± 14
pg/min. p < 0.05) providing pharmacologic evidence of the heart failure state,
CHF hearts had a depressed and dilated LV as assessed by the ESPVR slope,
Ees, and volume axis intercept, Yo, (both normalized to LV mass) compared
to control (TABLE). EDPVR of CHF hearts was shifted to the right compared to
control. Systolic and diastolic stress-strain relationships. estimated from the
pressure-volume relations. were similar in the two groups. These data sug-
gest that with the degree of chronic ischemic damage achieved, there was
systolic LV chamber dysfunction and chamber remodeling but not myocar-
dial property changes in surviving muscle. The mVOz-PVA relation in CHF
hearts had smaller mV02-intercept (B) than control with no change in the
slope (A) (TABLE), This contrasts with a previous report using a rapid pacing
CHF model in which myocardial strength was decreased, A was decreased
and B was unchanged. These data suggest that 1) in spite of the notable
structural and functional changes in chamber mechanics. energetic aspects
of the failing heart remained unaltered in this model and 2) conclusions about
myocardial energetics in CHF are model dependent.
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1727-31 Regulation of Endogenous Adenosine Improves
Myocardial Functional Recovery Following
Ischemia/Reperfusion Injury
Michael A, Kurz. Kevin Mullane. Mark A. Young. Gensia Inc., San Diego, CA
Adenosine (ADO) has been shown to be cardioprotective following is-
chemia/reperfusion injury. but its utility is limited by profound hemody-
namic side-effects. Therefore, we studied the effects of a novel ADO reg-
ulating agent, GP531 (5-amino-l-p-D-(5-benzylamino-5-deoxy-ribofuranosyl)
imidazole-4-carboxamide), on functional recovery following myocardial stun-
ning in pigs. GP531 does not bind to ADO A1. A2. or A3 receptors, but
increases local endogenous ADO concentrations, Anesthetized pigs were
treated with GP531 (lor 1Ollg!kg/min, iv) orvehicle (saline) in the presence or
absence of the ADO-receptor antagonist 8-sulfophenyltheophylline (8SPT. 83
* p < 0.05. ** P < 0.01 vs. Control by ANCOVA
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Differential Role of Circulating and Ventricular ANP
as a Marker for Cardiac Filling Pressures and
Ventricular Remodeling In a Model of Pacing Induced
Heart Failure and Cardiac Hypertrophy
Margaret M. Redfield. Tracy L, Stevens, Lawrence L. Aarhus, Lane M. Meyer, John
C. Burnett. Jr.. Mayo Clinic. Rochester, MN
Previous studies have suggested that circulating atrial natriuretic peptide
(ANP) is a marker for cardiac filling pressures and ventricular myocardial pro-
duction of ANP a marker for ventricular hypertrophy and/or dilatation. To ad-
dress the role of circulating ANP as a marker for ventricular hypertrophy and
dilatation as compared to cardiac filling pressures, we developed a new ca-
nine model of pacing induced heart failure that in contrast to previous pacing
models produces sustained ventricular hypertrophy. This involves gradually
increasing the pacing rate from 180 to 240 bpm over 30 days (PROG PACE,
n = 5) followed by 4 weeks of recovery (REC. n = 6). Four NORMAL dogs
served as controls, Diastolic dimension (LVEDd) and EF were assessed by
echo, LV mass was assessed by echo prior to rapid ventricular pacing (pre-
RVP) in the PROG PACE (4.2 ± 0.2 g/kg) and REC (4,7 ± 0.2 g/kg) dogs. LV
0,030 ± 0.005**
0036 ± 0004
(13 ± 04) x 10-5
(1,3 ± 0.6) x 10-5
6.9 ± 5.3**
0.5 ± 2,9
3.9 ± 1.2*
47 ± 1.9
CHF
Control
